⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Cell and Gene Therapy Market Size to Worth USD 232.22 Billion, Rising at 24% CAGR by 2035
globenewswire.com
AMGN
BIIB
NVS
PFE
REGN
NTLA
ALNY
Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses
globenewswire.com
NVS
MCHX
Novel Agent Ianalumab Added to Standard Therapy Extends Time to Treatment Failure in Patients with Previously Treated Immune Thrombocytopenia
prnewswire.com
NVS
1 in 4 metastatic breast cancer patients treated with Novartis Kisqali® remain progression-free beyond 4 years
globenewswire.com
NVS
Relation announces strategic collaboration with Novartis to advance therapeutics for atopic diseases
globenewswire.com
NVS
Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
AMGN
PFE
LLY
AZN
BMY
NVS
SNY
GSK
UCB
ARQT
REGN
INCY
ABBV
BIIB
MRK
JNJ
VNDA
RAPT
CHAI
ONON
ION
ASMB
CRVS
APG
KSCP
KYMR
XBI
IBB
ADSK
CDNS
SNPS
Neuroblastoma Market - A Global and Regional Analysis: Focus on Treatment and Regional Analysis - Analysis and Forecast, 2025-2035
globenewswire.com
NVS
LLY
Global Demand Spurs Competition in CAR T-Cell Therapy for Multiple Myeloma
globenewswire.com
BMY
JNJ
NVS
GILD
John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scientific Conference
globenewswire.com
AMGN
REGN
GILD
BMY
AZN
NVS
ARGX
BIIB
BBIO
SRRK
CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035 by Target Antigens, Target Indication, Key Geographies, Sales Forecast of Drugs and Leading Players
globenewswire.com
BMY
GILD
NVS